A study of the immune response to vaccination in MS patients treated with alemtuzumab

Authors
Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2009
This article has no abstract
Epistemonikos ID: 85f230c6d18994090b6c6671249ffd4469336c36
First added on: Jul 27, 2021